{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T20:54:05Z","timestamp":1780520045069,"version":"3.54.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,1,16]],"date-time":"2009-01-16T00:00:00Z","timestamp":1232064000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s11064-008-9904-5","type":"journal-article","created":{"date-parts":[[2009,1,15]],"date-time":"2009-01-15T12:03:34Z","timestamp":1232021014000},"page":"1261-1271","source":"Crossref","is-referenced-by-count":52,"title":["Metabonomic Characterization of the 3-Nitropropionic Acid Rat Model of Huntington\u2019s Disease"],"prefix":"10.1007","volume":"34","author":[{"given":"T. M.","family":"Tsang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. N.","family":"Haselden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,1,16]]},"reference":[{"key":"9904_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ana.410310113","volume":"31","author":"GJ Harris","year":"1992","unstructured":"Harris GJ, Pearlson GD, Peyser CE et al (1992) Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington\u2019s disease. Ann Neurol 31:69\u201375. doi: 10.1002\/ana.410310113","journal-title":"Ann Neurol"},{"key":"9904_CR2","first-page":"615","volume":"45","author":"RH Myers","year":"1989","unstructured":"Myers RH, Leavitt J, Farrer LA et al (1989) Homozygote for Huntington disease. Am J Hum Genet 45:615\u2013618","journal-title":"Am J Hum Genet"},{"key":"9904_CR3","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1021\/pr050244o","volume":"5","author":"TM Tsang","year":"2006","unstructured":"Tsang TM, Woodman B, McLoughlin GA et al (2006) Metabolic characterization of the R6\/2 transgenic mouse model of Huntington\u2019s disease by high-resolution MAS 1H NMR spectroscopy. J Proteome Res 5:483\u2013492. doi: 10.1021\/pr050244o","journal-title":"J Proteome Res"},{"key":"9904_CR4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2135\/cropsci1979.0011183X001900020007x","volume":"19","author":"DL Gustine","year":"1979","unstructured":"Gustine DL (1979) Aliphatic nitrocompounds in crownvetch. Crop Sci 19:197\u2013203","journal-title":"Crop Sci"},{"key":"9904_CR5","unstructured":"Wilson BJ (1971) Miscellaneous Aspergillus toxins. In: Ciegler A, Kadis S, Ajl SJ (eds) Microbial toxins, vol 6. Academic Press, New York, pp 251\u2013257"},{"key":"9904_CR6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2990.1982.tb00306.x","volume":"8","author":"DH Gould","year":"1982","unstructured":"Gould DH, Gustine DL (1982) Basal ganglia degeneration, myelin alterations, and enzyme inhibition induced in mice by the plant toxin 3-nitropropanoic acid. Neuropathol Appl Neurobiol 8:377\u2013393. doi: 10.1111\/j.1365-2990.1982.tb00306.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"9904_CR7","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1749-6632.1992.tb24562.x","volume":"648","author":"AC Ludolph","year":"1992","unstructured":"Ludolph AC, Seelig M, Ludolph AG et al (1992) ATP deficits and neuronal degeneration induced by 3-nitropropionic acid. Ann NY Acad Sci 648:300\u2013302. doi: 10.1111\/j.1749-6632.1992.tb24562.x","journal-title":"Ann N Y Acad Sci"},{"key":"9904_CR8","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1017\/S0317167100032212","volume":"18","author":"AC Ludolph","year":"1991","unstructured":"Ludolph AC, He F, Spencer PS et al (1991) 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin. Can J Neurol Sci 18:492\u2013498","journal-title":"Can J Neurol Sci"},{"key":"9904_CR9","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1212\/WNL.45.12.2178","volume":"45","author":"F He","year":"1995","unstructured":"He F, Zhang S, Qian F et al (1995) Delayed dystonia with striatal CT lucencies induced by a mycotoxin (3-nitropropionic acid). Neurology 45:2178\u20132183","journal-title":"Neurology"},{"key":"9904_CR10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0378-4274(85)90123-7","volume":"27","author":"DH Gould","year":"1985","unstructured":"Gould DH, Wilson MP, Hamar DW (1985) Brain enzyme and clinical alterations induced in rats and mice by nitroaliphatic toxicants. Toxicol Lett 27:83\u201389. doi: 10.1016\/0378-4274(85)90123-7","journal-title":"Toxicol Lett"},{"key":"9904_CR11","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.1471-4159.1998.70020794.x","volume":"70","author":"E Brouillet","year":"1998","unstructured":"Brouillet E, Guyot MC, Mittoux V et al (1998) Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J Neurochem 70:794\u2013805","journal-title":"J Neurochem"},{"key":"9904_CR12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0306-4522(96)00602-1","volume":"79","author":"MC Guyot","year":"1997","unstructured":"Guyot MC, Hantraye P, Dolan R et al (1997) Quantifiable bradykinesia, gait abnormalities and Huntington\u2019s disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid. Neuroscience 79:45\u201356. doi: 10.1016\/S0306-4522(96)00602-1","journal-title":"Neuroscience"},{"key":"9904_CR13","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1097\/00001756-199410270-00035","volume":"5","author":"M Riepe","year":"1994","unstructured":"Riepe M, Ludolph A, Seelig M et al (1994) Increase of ATP levels by glutamate antagonists is unrelated to neuroprotection. NeuroReport 5:2130\u20132132. doi: 10.1097\/00001756-199410270-00035","journal-title":"NeuroReport"},{"key":"9904_CR14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0014-2999(99)00147-8","volume":"370","author":"EM Urbanska","year":"1999","unstructured":"Urbanska EM, Blaszczak P, Saran T et al (1999) AMPA\/kainate-related mechanisms contribute to convulsant and proconvulsant effects of 3-nitropropionic acid. Eur J Pharmacol 370:251\u2013256. doi: 10.1016\/S0014-2999(99)00147-8","journal-title":"Eur J Pharmacol"},{"key":"9904_CR15","first-page":"89","volume":"95","author":"WT Lee","year":"2000","unstructured":"Lee WT, Shen YZ, Chang C (2000) Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid: evaluation by magnetic resonance imaging and in vivo proton magnetic resonance spectroscopy. Neuroscience 95:89\u201395. doi: 10.1016\/S0306-4522(99)00410-8","journal-title":"Neuroscience"},{"key":"9904_CR16","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","volume":"13","author":"MF Beal","year":"1993","unstructured":"Beal MF, Brouillet E, Jenkins BG et al (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13:4181\u20134192","journal-title":"J Neurosci"},{"key":"9904_CR17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00004647-200001000-00016","volume":"20","author":"GW Kim","year":"2000","unstructured":"Kim GW, Copin JC, Kawase M et al (2000) Excitotoxicity is required for induction of oxidative stress and apoptosis in mouse striatum by the mitochondrial toxin, 3-nitropropionic acid. J Cereb Blood Flow Metab 20:119\u2013129. doi: 10.1097\/00004647-200001000-00016","journal-title":"J Cereb Blood Flow Metab"},{"key":"9904_CR18","doi-asserted-by":"crossref","unstructured":"Andrew ER, Eades RG (1959) Removal of dipolar broadening of NMR spectra of solids by spectral rotation. Nature 183:1802. doi: 10.1038\/1831802a0","DOI":"10.1038\/1831802a0"},{"key":"9904_CR19","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/mrm.1910360502","volume":"36","author":"LL Cheng","year":"1996","unstructured":"Cheng LL, Lean CL, Bogdanova A et al (1996) Enhanced resolution of proton NMR spectra of malignant lymph nodes using magic-angle spinning. Magn Reson Med 36:653\u2013658. doi: 10.1002\/mrm.1910360502","journal-title":"Magn Reson Med"},{"key":"9904_CR20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/mrm.1910380307","volume":"38","author":"KK Millis","year":"1997","unstructured":"Millis KK, Maas WE, Cory DG et al (1997) Gradient, high-resolution, magic-angle spinning nuclear magnetic resonance spectroscopy of human adipocyte tissue. Magn Reson Med 38:399\u2013403. doi: 10.1002\/mrm.1910380307","journal-title":"Magn Reson Med"},{"key":"9904_CR21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/abio.2000.4574","volume":"282","author":"NJ Waters","year":"2000","unstructured":"Waters NJ, Garrod S, Farrant RD et al (2000) High-resolution magic angle spinning (1)H NMR spectroscopy of intact liver and kidney: optimization of sample preparation procedures and biochemical stability of tissue during spectral acquisition. Anal Biochem 282:16\u201323. doi: 10.1006\/abio.2000.4574","journal-title":"Anal Biochem"},{"key":"9904_CR22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/jmre.1998.1578","volume":"135","author":"LL Cheng","year":"1998","unstructured":"Cheng LL, Chang IW, Smith BL et al (1998) Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy. J Magn Reson 135:194\u2013202. doi: 10.1006\/jmre.1998.1578","journal-title":"J Magn Reson"},{"key":"9904_CR23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/mrm.1910380224","volume":"38","author":"E Humpfer","year":"1997","unstructured":"Humpfer E, Spraul M, Nicholls AW et al (1997) Direct observation of resolved intracellular and extracellular water signals in intact human red blood cells using 1H MAS NMR spectroscopy. Magn Reson Med 38:334\u2013336. doi: 10.1002\/mrm.1910380224","journal-title":"Magn Reson Med"},{"key":"9904_CR24","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/mrm.20447","volume":"53","author":"TM Tsang","year":"2005","unstructured":"Tsang TM, Griffin JL, Haselden J et al (2005) Metabolic characterization of distinct neuroanatomical regions in rats by magic angle spinning 1H nuclear magnetic resonance spectroscopy. Magn Reson Med 53:1018\u20131024. doi: 10.1002\/mrm.20447","journal-title":"Magn Reson Med"},{"key":"9904_CR25","unstructured":"Montgomerie H (1980) In: Drury RAB, Wallington EA (eds) Carleton\u2019s histological technique, 5 edn. Oxford University Press, Oxford"},{"key":"9904_CR26","unstructured":"Bancroft JD, Stevens A (1982) In: Bancroft JD, Stevens A (eds) Theory and practice of histological techniques. Churchill Livingstone, Edinburgh"},{"key":"9904_CR27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1159\/000020549","volume":"6","author":"PJ Foxall","year":"1998","unstructured":"Foxall PJ, Nicholson JK (1998) Nuclear magnetic resonance spectroscopy: a non-invasive probe of kidney metabolism and function. Exp Nephrol 6:409\u2013414. doi: 10.1159\/000020549","journal-title":"Exp Nephrol"},{"key":"9904_CR28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0006-2952(02)01016-X","volume":"64","author":"NJ Waters","year":"2002","unstructured":"Waters NJ, Holmes E, Waterfield CJ et al (2002) NMR and pattern recognition studies on liver extracts and intact livers from rats treated with alpha-naphthylisothiocyanate. Biochem Pharmacol 64:67\u201377. doi: 10.1016\/S0006-2952(02)01016-X","journal-title":"Biochem Pharmacol"},{"key":"9904_CR29","first-page":"1417","volume":"16","author":"J Henke","year":"1996","unstructured":"Henke J, Willker W, Engelmann J et al (1996) Combined extraction techniques of tumour cells and lipid\/phospholipid assignment by two dimensional NMR spectroscopy. Anticancer Res 16:1417\u20131427","journal-title":"Anticancer Res"},{"key":"9904_CR30","unstructured":"Wold S, Johannsson E, Cocchi M (1993) 3D-QSAR in drug design, theory, methods, and applications. ESCOM Science"},{"key":"9904_CR31","volume-title":"Prediction Methods in Science and Technology","author":"A Hoskuldsson","year":"1996","unstructured":"Hoskuldsson A (1996) Prediction methods in science and technology. Thor Publishing, Copenhagen"},{"key":"9904_CR32","unstructured":"Wold S, Albano C, Dunn WJ et al (1984) In: Kowalski BR (ed) Mutlivariate data analysis in chemistry. D. Reidel Publishing Company, Dordrecht"},{"key":"9904_CR33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1471-4159.2000.0750453.x","volume":"75","author":"MH Baslow","year":"2000","unstructured":"Baslow MH (2000) Functions of N-acetyl-l-aspartate and N-acetyl-l-aspartylglutamate in the vertebrate brain: role in glial cell-specific signaling. J Neurochem 75:453\u2013459. doi: 10.1046\/j.1471-4159.2000.0750453.x","journal-title":"J Neurochem"},{"key":"9904_CR34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF00691103","volume":"72","author":"BF Hamilton","year":"1987","unstructured":"Hamilton BF, Gould DH (1987) Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage. Acta Neuropathol 72:286\u2013297. doi: 10.1007\/BF00691103","journal-title":"Acta Neuropathol"},{"key":"9904_CR35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00688340","volume":"74","author":"BF Hamilton","year":"1987","unstructured":"Hamilton BF, Gould DH (1987) Correlation of morphologic brain lesions with physiologic alterations and blood-brain barrier impairment in 3-nitropropionic acid toxicity in rats. Acta Neuropathol 74:67\u201374. doi: 10.1007\/BF00688340","journal-title":"Acta Neuropathol"},{"key":"9904_CR36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1365-2990.1999.00212.x","volume":"25","author":"JC Vis","year":"1999","unstructured":"Vis JC, Verbeek MM, De Waal RM et al (1999) 3-Nitropropionic acid induces a spectrum of Huntington\u2019s disease-like neuropathology in rat striatum. Neuropathol Appl Neurobiol 25:513\u2013521. doi: 10.1046\/j.1365-2990.1999.00212.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"9904_CR37","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/00004647-200005000-00005","volume":"20","author":"C Dautry","year":"2000","unstructured":"Dautry C, Vaufrey F, Brouillet E et al (2000) Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid. J Cereb Blood Flow Metab 20:789\u2013799. doi: 10.1097\/00004647-200005000-00005","journal-title":"J Cereb Blood Flow Metab"},{"key":"9904_CR38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jns.2007.05.035","volume":"263","author":"WR Martin","year":"2007","unstructured":"Martin WR, Wieler M, Hanstock CC (2007) Is brain lactate increased in Huntington\u2019s disease? J Neurol Sci 263:70\u201374. doi: 10.1016\/j.jns.2007.05.035","journal-title":"J Neurol Sci"},{"key":"9904_CR39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF02109358","volume":"10","author":"Z Binienda","year":"1995","unstructured":"Binienda Z, Frederick DL, Ferguson SA et al (1995) The effects of perinatal hypoxia on the behavioral, neurochemical, and neurohistological toxicity of the metabolic inhibitor 3-nitropropionic acid. Metab Brain Dis 10:269\u2013282. doi: 10.1007\/BF02109358","journal-title":"Metab Brain Dis"},{"key":"9904_CR40","first-page":"1220","volume":"21","author":"I Mader","year":"2000","unstructured":"Mader I, Roser W, Kappos L et al (2000) Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2\u00a0years during a clinical pharmacological study. AJNR Am J Neuroradiol 21:1220\u20131227","journal-title":"AJNR Am J Neuroradiol"},{"key":"9904_CR41","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/mrm.1910340511","volume":"34","author":"PM Stefano NMatthews De","year":"1995","unstructured":"De Stefano NMatthews PM, Arnold DL (1995) Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 34:721\u2013727. doi: 10.1002\/mrm.1910340511","journal-title":"Magn Reson Med"},{"key":"9904_CR42","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/00001756-199605310-00014","volume":"7","author":"TE Bates","year":"1996","unstructured":"Bates TE, Strangward M, Keelan J et al (1996) Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. NeuroReport 7:1397\u20131400. doi: 10.1097\/00001756-199605310-00014","journal-title":"NeuroReport"},{"key":"9904_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/brain\/94.1.1","volume":"94","author":"VJ Montpetit","year":"1971","unstructured":"Montpetit VJ, Andermann F, Carpenter S et al (1971) Subacute necrotizing encephalomyelopathy A review and a study of two families. Brain 94:1\u201330. doi: 10.1093\/brain\/94.1.1","journal-title":"Brain"},{"key":"9904_CR44","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1212\/WNL.36.8.1053","volume":"36","author":"EJ Novotny Jr","year":"1986","unstructured":"Novotny EJ Jr, Singh G, Wallace DC et al (1986) Leber\u2019s disease and dystonia: a mitochondrial disease. Neurology 36:1053\u20131060","journal-title":"Neurology"},{"key":"9904_CR45","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1046\/j.1471-4159.1995.65031184.x","volume":"65","author":"B Hassel","year":"1995","unstructured":"Hassel B, Sonnewald U (1995) Selective inhibition of the tricarboxylic acid cycle of GABAergic neurons with 3-nitropropionic acid in vivo. J Neurochem 65:1184\u20131191","journal-title":"J Neurochem"},{"key":"9904_CR46","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/263517a0","volume":"263","author":"EG McGeer","year":"1976","unstructured":"McGeer EG, McGeer PL (1976) Duplication of biochemical changes of Huntington\u2019s chorea by intrastriatal injections of glutamic and kainic acids. Nature 263:517\u2013519. doi: 10.1038\/263517a0","journal-title":"Nature"},{"key":"9904_CR47","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00019052-199412000-00012","volume":"7","author":"MF Beal","year":"1994","unstructured":"Beal MF (1994) Neurochemistry and toxin models in Huntington\u2019s disease. Curr Opin Neurol 7:542\u2013547. doi: 10.1097\/00019052-199412000-00012","journal-title":"Curr Opin Neurol"},{"key":"9904_CR48","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0006-8993(96)00307-1","volume":"730","author":"PV Cicchetti FGould","year":"1996","unstructured":"Cicchetti FGould PV, Parent A (1996) Sparing of striatal neurons coexpressing calretinin and substance P (NK1) receptor in Huntington\u2019s disease. Brain Res 730:232\u2013237","journal-title":"Brain Res"},{"key":"9904_CR49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(98)00648-7","volume":"359","author":"EM Urbanska","year":"1998","unstructured":"Urbanska EM, Blaszczak P, Saran T et al (1998) Mitochondrial toxin 3-nitropropionic acid evokes seizures in mice. Eur J Pharmacol 359:55\u201358. doi: 10.1016\/S0014-2999(98)00648-7","journal-title":"Eur J Pharmacol"},{"key":"9904_CR50","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0301-0082(99)00005-2","volume":"59","author":"E Brouillet","year":"1999","unstructured":"Brouillet E, Conde F, Beal MF et al (1999) Replicating Huntington\u2019s disease phenotype in experimental animals. Prog Neurobiol 59:427\u2013468. doi: 10.1016\/S0301-0082(99)00005-2","journal-title":"Prog Neurobiol"},{"key":"9904_CR51","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/0024-3205(87)90098-1","volume":"40","author":"A Schurr","year":"1987","unstructured":"Schurr A, Tseng MT, West CA et al (1987) Taurine improves the recovery of neuronal function following cerebral hypoxia: an in vitro study. Life Sci 40:2059\u20132066. doi: 10.1016\/0024-3205(87)90098-1","journal-title":"Life Sci"},{"key":"9904_CR52","first-page":"289","volume":"179","author":"A Lehmann","year":"1985","unstructured":"Lehmann A, Hagberg H, Nystrom B et al (1985) In vivo regulation of extracellular taurine and other neuroactive amino acids in the rabbit hippocampus. Prog Clin Biol Res 179:289\u2013311","journal-title":"Prog Clin Biol Res"},{"key":"9904_CR53","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0197-0186(98)00051-5","volume":"33","author":"RO Law","year":"1998","unstructured":"Law RO (1998) The role of taurine in the regulation of brain cell volume in chronically hyponatraemic rats. Neurochem Int 33:467\u2013472. doi: 10.1016\/S0197-0186(98)00051-5","journal-title":"Neurochem Int"},{"key":"9904_CR54","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/978-1-4899-0182-8_66","volume":"403","author":"RF Butterworth","year":"1996","unstructured":"Butterworth RF (1996) Taurine in hepatic encephalopathy. Adv Exp Med Biol 403:601\u2013606","journal-title":"Adv Exp Med Biol"},{"key":"9904_CR55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0304-3940(93)90458-W","volume":"156","author":"R Sanchez-Olea","year":"1993","unstructured":"Sanchez-Olea R, Pena C, Moran J et al (1993) Inhibition of volume regulation and efflux of osmoregulatory amino acids by blockers of Cl- transport in cultured astrocytes. Neurosci Lett 156:141\u2013144. doi: 10.1016\/0304-3940(93)90458-W","journal-title":"Neurosci Lett"},{"key":"9904_CR56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/09540260600581852","volume":"18","author":"BK Puri","year":"2006","unstructured":"Puri BK (2006) Proton and 31-phosphorus neurospectroscopy in the study of membrane phospholipids and fatty acid intervention in schizophrenia, depression, chronic fatigue syndrome (myalgic encephalomyelitis) and dyslexia. Int Rev Psychiatry 18:145\u2013147. doi: 10.1080\/09540260600581852","journal-title":"Int Rev Psychiatry"},{"key":"9904_CR57","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","volume":"43","author":"BG Jenkins","year":"1993","unstructured":"Jenkins BG, Koroshetz WJ, Beal MF et al (1993) Evidence for impairment of energy metabolism in vivo in Huntington\u2019s disease using localized 1H NMR spectroscopy. Neurology 43:2689\u20132695","journal-title":"Neurology"},{"key":"9904_CR58","doi-asserted-by":"crossref","first-page":"19686","DOI":"10.1074\/jbc.274.28.19686","volume":"274","author":"M Anthony MLZhao","year":"1999","unstructured":"Anthony MLZhao M, Brindle KM (1999) Inhibition of phosphatidylcholine biosynthesis following induction of apoptosis in HL-60 cells. J Biol Chem 274:19686\u201319692. doi: 10.1074\/jbc.274.28.19686","journal-title":"J Biol Chem"},{"key":"9904_CR59","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1182\/blood.V89.10.3778","volume":"89","author":"FG Blankenberg","year":"1997","unstructured":"Blankenberg FG, Katsikis PD, Storrs RW et al (1997) Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy. Blood 89:3778\u20133786","journal-title":"Blood"},{"key":"9904_CR60","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1182\/blood.V87.5.1951.1951","volume":"87","author":"FG Blankenberg","year":"1996","unstructured":"Blankenberg FG, Storrs RW, Naumovski L et al (1996) Detection of apoptotic cell death by proton nuclear magnetic resonance spectroscopy. Blood 87:1951\u20131956","journal-title":"Blood"},{"key":"9904_CR61","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0006-8993(92)90925-Y","volume":"580","author":"DM Dunlop DSMc Hale","year":"1992","unstructured":"Dunlop DSMc Hale DM, Lajtha A (1992) Decreased brain N-acetylaspartate in Huntington\u2019s disease. Brain Res 580:44\u201348. doi: 10.1016\/0006-8993(92)90925-Y","journal-title":"Brain Res"},{"key":"9904_CR62","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1212\/WNL.42.8.1578","volume":"42","author":"WE Klunk","year":"1992","unstructured":"Klunk WE, Panchalingam K, Moossy J et al (1992) N-Acetyl-l-aspartate and other amino acid metabolites in Alzheimer\u2019s disease brain: a preliminary proton nuclear magnetic resonance study. Neurology 42:1578\u20131585","journal-title":"Neurology"},{"key":"9904_CR63","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1212\/WNL.43.3_Part_1.509","volume":"43","author":"DJ Meyerhoff","year":"1993","unstructured":"Meyerhoff DJ, MacKay S, Bachman L et al (1993) Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging. Neurology 43:509\u2013515","journal-title":"Neurology"},{"key":"9904_CR64","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/jcbfm.1994.48","volume":"14","author":"T Ebisu","year":"1994","unstructured":"Ebisu T, Rooney WD, Graham SH et al (1994) N-Acetylaspartate as an in vivo marker of neuronal viability in kainate-induced status epilepticus: 1H magnetic resonance spectroscopic imaging. J Cereb Blood Flow Metab 14:373\u2013382","journal-title":"J Cereb Blood Flow Metab"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-008-9904-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-008-9904-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-008-9904-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T18:43:57Z","timestamp":1589481837000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-008-9904-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,16]]},"references-count":64,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["9904"],"URL":"https:\/\/doi.org\/10.1007\/s11064-008-9904-5","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,16]]}}}